Cargando…
Early Initiation of Anticoagulation Improves the Long-Term Prognosis in Patients With Antiphospholipid Syndrome Associated Portal Vein Thrombosis
Objectives: Portal vein thrombosis (PVT) is a rare and severe clinical phenotype of antiphospholipid syndrome (APS) with a poor prognosis. Anticoagulation therapy is efficient but is associated with potentially severe bleeding episodes, especially for those patients with thrombocytopenia. We conduct...
Autores principales: | You, Hanxiao, Zhao, Jiuliang, Huang, Can, Tian, Xinping, Li, Mengtao, Zeng, Xiaofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890015/ https://www.ncbi.nlm.nih.gov/pubmed/33614687 http://dx.doi.org/10.3389/fmed.2021.630660 |
Ejemplares similares
-
Recurrent Non-stroke Central Neurologic Manifestations in Primary Antiphospholipid Syndrome
por: You, Hanxiao, et al.
Publicado: (2022) -
Validation of three prediction models for thrombosis recurrence in antiphospholipid syndrome patients based on a prospective cohort
por: Zhao, Yuan, et al.
Publicado: (2023) -
Extra-criteria clinical manifestations of antiphospholipid antibody should not be ignored
por: Huang, Can, et al.
Publicado: (2022) -
Sex Differences in Clinical Characteristics and Prognosis in Primary Thrombotic Antiphospholipid Syndrome
por: Huang, Yongfa, et al.
Publicado: (2022) -
Immunoglobulin A Isotype of Antiphospholipid Antibodies Does Not Provide Added Value for the Diagnosis of Antiphospholipid Syndrome in a Chinese Population
por: Hu, Chaojun, et al.
Publicado: (2020)